GHK-Cu
Copper-binding tripeptide studied for skin and hair follicle signaling.
GHK-Cu is Copper-binding tripeptide studied for skin and hair follicle signaling. Whether it is appropriate depends on your medical history, goals, current medications, and testing — evaluated by a licensed VidaVital Medical provider during a live consultation. Educational content only; not medical advice.
- GHK-Cu is available as a compounded prescription (not FDA-approved).
- Your provider determines whether testing is needed.
- Providers may evaluate it in aesthetic.
- A licensed VidaVital provider must complete a live consultation before any treatment is prescribed.
What is it?
Copper-binding tripeptide studied for skin and hair follicle signaling. A licensed provider reviews suitability, monitoring, and any needed testing during a live consultation.
What may it support?
- Skin research
- Hair follicle research
Where might it fit?
Bloodwork & monitoring
Potential side effects
- Injection-site reaction
- Mild GI discomfort
- Rare allergic reaction
Who may not be a candidate?
- • Pregnancy
- • Active malignancy without oncology clearance
Drug interactions
- • Providers review all medications during consultation
Regulatory disclosures
Speak With a Licensed Medical Provider
If you're interested in learning whether peptide therapy may be appropriate for your health goals, schedule a consultation with a licensed VidaVital Medical provider. Your provider will review your medical history, discuss available treatment options, and determine whether any therapy is appropriate for your individual needs.
Frequently asked questions
Sources
- Provider-reviewed clinical summary — reviewed 2026-01-15 by VidaVital Medical
